{
    "id": 10474,
    "fullName": "FGFR1 - TACC1",
    "impact": "fusion",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "FGFR1-TACC1 results from the fusion of FGFR1 and TACC1, demonstrating transforming ability in culture, tumor growth in xenografts, and increased errors in chromosomal segregation (PMID: 22837387).",
            "references": [
                {
                    "id": 3426,
                    "pubMedId": 22837387,
                    "title": "Transforming fusions of FGFR and TACC genes in human glioblastoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22837387"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 2260,
        "geneSymbol": "FGFR1",
        "terms": [
            "FGFR1",
            "bFGF-R-1",
            "BFGFR",
            "CD331",
            "CEK",
            "ECCL",
            "FGFBR",
            "FGFR-1",
            "FLG",
            "FLT-2",
            "FLT2",
            "HBGFR",
            "HH2",
            "HRTFDS",
            "KAL2",
            "N-SAM",
            "OGD"
        ]
    },
    "variant": "FGFR1 - TACC1",
    "createDate": "08/11/2015",
    "updateDate": "09/11/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        {
            "gene": {
                "id": 6867,
                "geneSymbol": "TACC1",
                "terms": [
                    "TACC1",
                    "Ga55"
                ]
            }
        }
    ],
    "evidence": [
        {
            "id": 2707,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, AZD4547 inhibited Fgfr1 kinase activity and cell growth in transformed cells expressing the FGFR1-TACC1 fusion in culture (PMID: 22837387).",
            "molecularProfile": {
                "id": 10477,
                "profileName": "FGFR1 - TACC1"
            },
            "therapy": {
                "id": 654,
                "therapyName": "AZD4547",
                "synonyms": null
            },
            "indication": {
                "id": 3070,
                "name": "malignant glioma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 3426,
                    "pubMedId": 22837387,
                    "title": "Transforming fusions of FGFR and TACC genes in human glioblastoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22837387"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 2705,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, PD173074 inhibited Fgfr1 kinase activity and cell growth in transformed cells expressing the FGFR1-TACC1 fusion in culture (PMID: 22837387).",
            "molecularProfile": {
                "id": 10477,
                "profileName": "FGFR1 - TACC1"
            },
            "therapy": {
                "id": 2948,
                "therapyName": "PD173074",
                "synonyms": null
            },
            "indication": {
                "id": 3070,
                "name": "malignant glioma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 3426,
                    "pubMedId": 22837387,
                    "title": "Transforming fusions of FGFR and TACC genes in human glioblastoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22837387"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 2708,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, BJG398 inhibited Fgfr1 kinase activity and cell growth in transformed cells expressing the FGFR1-TACC1 fusion in culture (PMID: 22837387).",
            "molecularProfile": {
                "id": 10477,
                "profileName": "FGFR1 - TACC1"
            },
            "therapy": {
                "id": 674,
                "therapyName": "BGJ398",
                "synonyms": null
            },
            "indication": {
                "id": 3070,
                "name": "malignant glioma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 3426,
                    "pubMedId": 22837387,
                    "title": "Transforming fusions of FGFR and TACC genes in human glioblastoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22837387"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 10477,
            "profileName": "FGFR1 - TACC1",
            "profileTreatmentApproaches": [
                {
                    "id": 7452,
                    "name": "FGFR1 Inhibitor",
                    "profileName": "FGFR1 - TACC1"
                },
                {
                    "id": 7453,
                    "name": "FGFR Inhibitor (Pan)",
                    "profileName": "FGFR1 - TACC1"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}